Your browser doesn't support javascript.
loading
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease.
Kneller, Daniel W; Li, Hui; Phillips, Gwyndalyn; Weiss, Kevin L; Zhang, Qiu; Arnould, Mark A; Jonsson, Colleen B; Surendranathan, Surekha; Parvathareddy, Jyothi; Blakeley, Matthew P; Coates, Leighton; Louis, John M; Bonnesen, Peter V; Kovalevsky, Andrey.
Afiliación
  • Kneller DW; Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Li H; Center for Nanophase Materials Sciences, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Phillips G; Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Weiss KL; Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Zhang Q; Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Arnould MA; Center for Nanophase Materials Sciences, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Jonsson CB; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, 38103, USA.
  • Surendranathan S; Institute for the Study of Host-Pathogen Systems, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Parvathareddy J; Regional Biocontainment Laboratory, The University of Tennessee Health Science Center, Memphis, TN, 38105, USA.
  • Blakeley MP; Regional Biocontainment Laboratory, The University of Tennessee Health Science Center, Memphis, TN, 38105, USA.
  • Coates L; Regional Biocontainment Laboratory, The University of Tennessee Health Science Center, Memphis, TN, 38105, USA.
  • Louis JM; Large Scale Structures Group, Institut Laue-Langevin, 71 Avenue des Martyrs, 38000, Grenoble, France.
  • Bonnesen PV; Second Target Station, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA.
  • Kovalevsky A; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, MD, 20892-0520, USA.
Nat Commun ; 13(1): 2268, 2022 04 27.
Article en En | MEDLINE | ID: mdl-35477935
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido